| Financial Year |
March 31 2023 |
| Monetary Funds |
16,110,920.47 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,400,000.00 |
| Accounts Receivable |
45,375,833.33 |
| Advances to Suppliers |
32,201,365.53 |
| Other Receivables |
36,774,250.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
191,864,606.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,489,400.66 |
| Total Current Assets |
331,216,376.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
984,011,166.24 |
| Investment Properties |
36,005,275.81 |
| Fixed Assetes |
80,618,460.09 |
| Under-construction Projects |
11,881,211.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,730,270.65 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
59,512,212.94 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,661,423,896.02 |
| Total Assets |
1,992,640,272.27 |
| Short-Term Loans |
169,211,614.20 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
31,276,066.04 |
| Accounts Received In Advance |
1,415,739.26 |
| Employee Compensation Payable |
5,071,080.55 |
| Taxes Payable |
6,075,365.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,994,749.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,878,594.83 |
| Other Current Liabilities |
2,043,245.88 |
| Sub-Total of Current Liabilities |
257,669,187.86 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
98,944,863.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
201,141,531.84 |
| Total Liabilities |
458,810,719.70 |
| Paid-In Capital(Or Share Stock) |
484,932,000.00 |
| Capital Surplus |
578,473,853.78 |
| Surplus Reserve |
123,973,317.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
150,568,026.63 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,533,829,552.57 |
| Owner's Equity（Stockholder's Equity） |
1,533,829,552.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,992,640,272.27 |
